Pharmaceuticals

Procrit Market Forecast 2026–2035: How to Leverage Market Growth

March 6, 2026March 8, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the procrit market from 2026–2035 with trusted insights from The Business Research Company

What was the valuation of the Procrit Market in 2026, and what figure is it projected to hit by 2030?

Historical growth can be attributed to the escalating occurrence of chronic kidney disease, a surge in anemia cases resulting from chemotherapy, the embrace of biologic therapies for anemia, the proliferation of dialysis treatment facilities, and enhanced access to prescribed anemia medications.

The projected growth during the forecast period is fueled by an intensified focus on personalized anemia care, the increasing integration of biosimilar alternatives, the expansion of programs for treating chronic diseases, a growing priority on enhancing patient quality of life, and greater investments aimed at optimizing biologic drugs. Simultaneously, significant trends expected in this period encompass a rise in the application of erythropoiesis-stimulating agents, increasing demand for various anemia management therapies, the broadening of supportive care treatments for oncology patients, an escalating emphasis on reducing the need for blood transfusions, and enhanced oversight of chronic anemia conditions.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20189&type=smp

Which Drivers Are Affecting Market Participation In The Procrit Market?

A surge in anemia cases is anticipated to boost the procrit market in the future. Anemia describes a condition where the body lacks sufficient healthy red blood cells or hemoglobin, impairing oxygen delivery to tissues. This rise in anemia is attributed to the growing global burden of chronic illnesses like kidney failure, cancer, and inflammatory disorders, alongside inadequate nutrition causing deficiencies in iron, vitamin B12, and folate. Procrit (epoetin alfa) offers treatment for anemia stemming from chronic kidney disease, chemotherapy, or specific HIV therapies. Its function involves stimulating red blood cell production, thereby lessening the necessity for blood transfusions in individuals with low hemoglobin. As an illustration, the National Center for Health Statistics, a US-based government agency, reported in December 2024 that the prevalence of anemia among individuals aged 2 and above in 2023 saw a 9.3% increase compared to 2021. Consequently, the growing incidence of anemia propels the procrit market. The escalating occurrence of chronic kidney diseases is set to drive the procrit market in the coming years. Chronic kidney disease denotes a condition where the kidneys progressively lose their capacity to filter waste from the bloodstream. The prevalence of these diseases is increasing due to elements such as an aging demographic, obesity, and various lifestyle factors combined with environmental influences. Procrit (epoetin alfa) is administered to individuals with chronic kidney disease to manage anemia by stimulating the creation of red blood cells, assisting in the maintenance of suitable hemoglobin levels, and diminishing the necessity for blood transfusions. For example, a report released in June 2023 by Kidney Research UK, a UK-based non-profit organization, indicated that approximately 7.2 million people in the UK are currently afflicted with chronic kidney disease, constituting over 10% of the populace. Within this group, 3.25 million are in advanced stages, with another 3.9 million in early stages. Projections suggest that by 2033, the population affected by chronic kidney disease will increase to 7.61 million. Thus, the growing prevalence of chronic kidney diseases fuels the procrit market.

What Segment Classifications Make Up The Procrit Market?

The procrit market covered in this report is segmented –

1) By Indications: Chronic Kidney Diseases, Human Immunodeficiency Virus (HIV) Infection, Chemotherapy

2) By Distribution Channel: Direct Sales, Pharmaceutical Wholesalers, Retail Pharmacies

3) By End Users: Hospitals, Outpatient Clinics, Home Care

Which Major Firms Are Strengthening Their Position In The Procrit Market?

Major companies operating in the procrit market are Amgen Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/procrit-global-market-report

Which Region Is Anticipated To See The Fastest Growth In The Procrit Market?

North America was the largest region in the procrit market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the procrit market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Procrit Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=20189&type=smp

Browse Through More Reports Similar to the Global Procrit Market 2026, By The Business Research Company

Biopreservation Market Report 2026

https://www.thebusinessresearchcompany.com/report/biopreservation-global-market-report

Market Research Services Market Report 2026

https://www.thebusinessresearchcompany.com/report/market-research-services-global-market-report

Data Lake Market Report 2026

https://www.thebusinessresearchcompany.com/report/data-lake-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795